156 related articles for article (PubMed ID: 31163445)
1. Understanding Factors Associated with Uptake of BRCA1/2 Genetic Testing among Orthodox Jewish Women in the USA Using a Mixed-Methods Approach.
Trivedi MS; Colbeth H; Yi H; Vanegas A; Starck R; Chung WK; Appelbaum PS; Kukafka R; Schechter I; Crew KD
Public Health Genomics; 2018; 21(5-6):186-196. PubMed ID: 31163445
[TBL] [Abstract][Full Text] [Related]
2. Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community.
Yi H; Trivedi MS; Crew KD; Schechter I; Appelbaum P; Chung WK; Allegrante JP; Kukafka R
Public Health Genomics; 2024; 27(1):57-67. PubMed ID: 38402864
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.
Tang EY; Trivedi MS; Kukafka R; Chung WK; David R; Respler L; Leifer S; Schechter I; Crew KD
Breast J; 2017 May; 23(3):333-337. PubMed ID: 27900810
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women.
Trivedi MS; Manley H; Yi H; Silverman T; Chung WK; Appelbaum PS; Starck R; Schecter I; Kukafka R; Crew KD
Fam Cancer; 2024 Apr; ():. PubMed ID: 38609522
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
[TBL] [Abstract][Full Text] [Related]
6. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
7. Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Frey MK; Sandler G; Sobolev R; Kim SH; Chambers R; Bassett RY; Martineau J; Sapra KJ; Boyd L; Curtin JP; Pothuri B; Blank SV
Gynecol Oncol; 2017 Jul; 146(1):123-128. PubMed ID: 28495237
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
10. Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens N; Kaur R; Meiser B; Andrews L
Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
[TBL] [Abstract][Full Text] [Related]
11. Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study.
Reisel D; Burnell M; Side L; Loggenberg K; Gessler S; Desai R; Sanderson S; Brady AF; Dorkins H; Wallis Y; Jacobs C; Legood R; Beller U; Tomlinson I; Wardle J; Menon U; Jacobs I; Manchanda R
BJOG; 2022 May; 129(6):959-968. PubMed ID: 34758513
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
Warner E; Foulkes W; Goodwin P; Meschino W; Blondal J; Paterson C; Ozcelik H; Goss P; Allingham-Hawkins D; Hamel N; Di Prospero L; Contiga V; Serruya C; Klein M; Moslehi R; Honeyford J; Liede A; Glendon G; Brunet JS; Narod S
J Natl Cancer Inst; 1999 Jul; 91(14):1241-7. PubMed ID: 10413426
[TBL] [Abstract][Full Text] [Related]
13. Exploring the discourse between genetic counselors and Orthodox Jewish community members related to reproductive genetic technology.
Mittman IS; Bowie JV; Maman S
Patient Educ Couns; 2007 Feb; 65(2):230-6. PubMed ID: 16987632
[TBL] [Abstract][Full Text] [Related]
14. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
15. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
[TBL] [Abstract][Full Text] [Related]
16. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
17. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Rosenthal E; Moyes K; Arnell C; Evans B; Wenstrup RJ
Breast Cancer Res Treat; 2015 Jan; 149(1):223-7. PubMed ID: 25476495
[TBL] [Abstract][Full Text] [Related]
18. Orthodox Jewish Thought Leaders' Insights Regarding BRCA Mutations: A Descriptive Study.
Bressler T; Popp B
J Oncol Pract; 2017 Apr; 13(4):e303-e309. PubMed ID: 27875073
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.
Schubert EL; Mefford HC; Dann JL; Argonza RH; Hull J; King MC
Genet Test; 1997; 1(1):41-6. PubMed ID: 10464624
[TBL] [Abstract][Full Text] [Related]
20. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]